動脈硬化症は,先端圧力を増加させ,液体バランスメカニズムによる溶液輸送を制限する
Willy V Bonneuil1,2, Daniel J Watson3, Sarajo K Mohanta4
1Department of Bioengineering, Imperial College London, London, United Kingdom. willy.bonneuil@univ-rennes.fr.
Biomechanics and modeling in mechanobiology
|September 1, 2025
まとめ
動脈硬化により 臨界液圧が上昇し,動脈媒介からの溶液輸送が妨げられます. この変化は 血管の壁内の免疫細胞の行動に影響します
科学分野:
- 心血管生物学
- 生物医学工学
- 病理生理学
背景:
- 血管アドベンチチアは周囲の組織との重要なインターフェースとして機能し,アテロゲネシスに役割を果たします.
- アドベンチアル・ヴァーサ・ヴァソラムとリンパ血管は,病状において再構成される間位液と溶液輸送の重要な調節体である.
- 動脈壁内の輸送動態を理解することは 動脈硬化症の進行を理解するために不可欠です
研究 の 目的:
- 溶解性メディエーター (リポタンパク質,サイトカイン) の動脈壁を通過する過程を数学的にモデル化し,調査する.
- これらの輸送メカニズムが 健康な状態と動脈硬化状態の違いを分析する.
- 液体ダイナミクスの変化が溶質の分布と免疫細胞の潜在的相互作用に与える影響を評価する.
主な方法:
- 動脈壁における流体流と溶液輸送をシミュレートする数学的モデルの構築.
- 可能な限り in vivo 測定を用いたモデルパラメータの導出
- 様々なパラメータが流体流と溶液輸送に及ぼす影響を決定するための広範な感度分析.
主要な成果:
- 血管系とリンパ系における変異したトランスムラルフロースのために,先発的な間位液圧が動脈硬化で上昇すると予測されています.
- リンパ液の蓄積に寄与する血管の割合は,健康な状態では40~80%から,動脈硬化症では60~90%まで増加する.
- 動脈硬化における媒介からアドベンチアへの溶液輸送の障害は,免疫細胞の動態に影響を及ぼす可能性のある濃度グラデーションを変化させます.
結論:
- 動脈硬化に起因する臨時流体動力学的変化は,動脈壁内の溶液輸送を著しく変化させます.
- 動脈硬化症における間位液圧の上昇とリンパ機能の変化は,免疫細胞の保持を外部弾性層の近くで促進する可能性があります.
- 外部アベンジチアの溶解物グラデントは,この領域からの免疫細胞の引き寄せを減少させ,炎症反応に影響を与える可能性があります.
関連する概念動画
Atherosclerosis I: Introduction
76
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
76
Hypertension II: Pathophysiology
77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
38
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
38
Heart Failure II: Pathophysiology
37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
Peripheral Artery Disease I: Introduction
32
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
32
Hormonal Regulation of Blood Pressure
3.1K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
3.1K


